Navigation Links
Richer parasite diversity leads to healthier frogs, says University of Colorado study
Date:5/21/2012

groups of animals."

Recent studies also have shown similar relationships between host diversity and the risk of disease in some plants, mammals, birds and coral. A decrease in vertebrate host species for ticks carrying Lyme disease, for example, can increase the risk of Lyme disease in humans, said Johnson.

"It could be that the most dangerous parasites occur in greater numbers in disturbed environments," said Hoverman, who recently accepted a position as assistant professor at Purdue University's forestry and natural resources department. "If we are trying to minimize disease risk in humans or in threatened groups of animals like amphibians, studies like this will be able to tell us which scenarios are most likely to occur."

The new study has implications for declining biodiversity being seen across the planet as a result of human activities, including amphibians, said Johnson. Roughly 40 percent of amphibian species around the world are in decline, and more than 200 have gone extinct since the 1970s, some as a result of the often-fatal chytrid fungus that infects amphibian skin. Some scientists argue that rapid global amphibian decline seen today is driving the next great mass extinction event, he said.

Trematodes have a complex life cycle that involve snails, amphibians and predators. Host snails release parasite larvae in the water, infecting amphibians and causing deformities that include extra or missing legs. Deformed frogs and toads rarely survive long because of their susceptibility to predators like wading birds, which ingest them and later release trematodes that infect other snails, completing the life cycle.

Deformed frogs first gained attention in the mid-1990s when a group of Minnesota schoolchildren discovered a pond where more than half of the leopard frogs had missing or extra limbs, said Johnson. Since then reports of deformed amphibians have been widespread in the United States, leading to specu
'/>"/>

Contact: Pieter Johnson
pieter.johnson@colorado.edu
303-492-5623
University of Colorado at Boulder
Source:Eurekalert  

Page: 1 2 3 4

Related biology news :

1. 1st census shows life in planet ocean is richer, more connected, more altered than expected
2. Lab tests show arthritis drug effective against global parasite
3. Scientists find Achilles heel in life-threatening malaria parasites
4. Weakness can be an advantage in surviving deadly parasites, a new study shows
5. Modified bone drug kills malaria parasite in mice
6. Malaria parasite goes bananas before sex: New study
7. Scientists characterize protein essential to survival of malaria parasite
8. Crucial gene activator in slow-killing parasite identified
9. Global warming changes balance between parasite and host in fish -- new study
10. How parasites modify plants to attract insects
11. Brain parasite directly alters brain chemistry
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Richer parasite diversity leads to healthier frogs, says University of Colorado study
(Date:4/2/2015)... 2, 2015 In the ... far outperforms the strongest competitors, showing outstanding performance ... the system is capable of a throughput of ... up to be ten times faster than most ... performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
(Date:4/1/2015)... , April 1, 2015   Medisafe ™, ... million users across iOS and Android ... begun integrating biofeedback into the platform to allow patients ... outcomes. For the first time, patients will be able ... a dose impacts important biometrics, such as glucose levels ...
(Date:3/24/2015)... Mar. 24, 2015 Research and Markets ... "Global Iris Recognition Market 2015-2019" report to ... Iris Recognition market to grow at a CAGR of ... report covers the present scenario and the growth prospects ... 2015-2019. To calculate the market size, the report considers ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... have discovered how two closely related proteins guide projections ... repelling these axons as they navigate the most miniscule ... remarkably precise connections. The discovery, reported April 28 ... belonging to the "semaphorin" family of guidance cues are ...
... As part of the Genome Canada Large-Scale Applied Research ... million to 16 projects across the country, the researchers ... function with the aim of identifying genes or proteins ... to target cancers and other diseases. The first ...
... by a parasitic fungus dramatically changes the behavior of tropical ... to become zombie-like and to die at a spot that ... team studied ants living high up in the rainforest canopy ... in the BioMed Central open-access journal BMC Ecology ...
Cached Biology News:Johns Hopkins scientists reveal nerve cells' navigation system 2Johns Hopkins scientists reveal nerve cells' navigation system 3OGI genomics researchers awarded $23 million 2OGI genomics researchers awarded $23 million 3Zombie ants have fungus on the brain, new research reveals 2
(Date:4/23/2015)... CA (PRWEB) April 23, 2015 Delpor, ... today announced that the United States Patent and Trademark ... Company’s NANOPOR™ technology. US Pat. No. ... Delpor’s microfabricated drug delivery device for the ... proprietary NANOPOR™ technology for the sustained (zero-order) release of ...
(Date:4/22/2015)... , April 22, 2015 /PRNewswire/ - BioAmber Inc. (NYSE and EURONEXT Paris:BIOA) today ... first quarter 2015 on Thursday, May 7, 2015 after ... a webcast and conference call for 4.30 pm ET ... Live audio of the conference call will be ... investors, members of the news media and the general ...
(Date:4/22/2015)... Calif. , April 22, 2015 ... and analytics, announced today that it has opened ... its continued growth and expansion.  The common stock ... Act, Section 506(c), a law intended to encourage ... regulations.  Prior to 506(c), small businesses largely relied ...
(Date:4/22/2015)... 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC Market: ... announce that Biohaven Pharmaceutical Holding Company Limited (Biohaven), ... to initiate a Phase 1 pharmacokinetic and biomarker ... Biohaven plans to initiate the trial no later ... in the Phase 1 study, Biohaven will move ...
Breaking Biology Technology:Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device 2Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device 3BioAmber Announces Webcast of Fiscal First Quarter 2015 Financial Results 2Steep Hill Launches $5M Limited Stock Offering 2Steep Hill Launches $5M Limited Stock Offering 3Portage's Biohaven to begin Phase 1 study in 3Q2015 and readying for Phase 3 study start by 1Q2016 2Portage's Biohaven to begin Phase 1 study in 3Q2015 and readying for Phase 3 study start by 1Q2016 3
... , , , , ... Inc.,(Nasdaq: SSRX ), a leading biotechnology company focused ... today announced that it has submitted its application for ... Drug,Administration ("SFDA") for Feraheme (ferumoxytol) Injection for intravenous,use. Feraheme ...
... , , ... enrollment of patients with acute ischemic stroke into its,Phase III ... at the Wolfson Medical Center, Israel. The MACSI trial involves,numerous ... Korea and Brazil. DP-b99 is D-Pharm,s most advanced product developed,for ...
... WASHINGTON, Dec. 29 The National Fragile X Foundation applauds ... Fragile X Syndrome for the first time ever within a ... U.S. Department of Defense. , The new law, ... through the FY 2010 Department of Defense Appropriations Act for ...
Cached Biology Technology:3SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM) 23SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM) 33SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM) 4D-Pharm (TASE: DPRM) Announces Enrollment of First Patient in DP-b99 Phase III Efficacy Study, MACSI 2D-Pharm (TASE: DPRM) Announces Enrollment of First Patient in DP-b99 Phase III Efficacy Study, MACSI 3Defense Department to Support Fragile X Research 2